Yan Hu1,2,3, Guobing Liu1,2,3, He Zhang1,2,3, Yanli Li1,2,3, Brian D Gray4, Koon Y Pak4, Hak Soo Choi5, Dengfeng Cheng6,7,8, Hongcheng Shi9,10,11. 1. Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, No. 180, Fenglin Road, Shanghai, 200032, People's Republic of China. 2. Shanghai Institute of Medical Imaging, Shanghai, 200032, China. 3. Institute of Nuclear Medicine, Fudan University, Shanghai, 200032, China. 4. Molecular Targeting Technologies, Inc., West Chester, PA, 19380, USA. 5. Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. 6. Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, No. 180, Fenglin Road, Shanghai, 200032, People's Republic of China. cheng.dengfeng@zs-hospital.sh.cn. 7. Shanghai Institute of Medical Imaging, Shanghai, 200032, China. cheng.dengfeng@zs-hospital.sh.cn. 8. Institute of Nuclear Medicine, Fudan University, Shanghai, 200032, China. cheng.dengfeng@zs-hospital.sh.cn. 9. Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, No. 180, Fenglin Road, Shanghai, 200032, People's Republic of China. shi.hongcheng@zs-hospital.sh.cn. 10. Shanghai Institute of Medical Imaging, Shanghai, 200032, China. shi.hongcheng@zs-hospital.sh.cn. 11. Institute of Nuclear Medicine, Fudan University, Shanghai, 200032, China. shi.hongcheng@zs-hospital.sh.cn.
Abstract
PURPOSE: Apoptosis is a key factor in unstable plaques. The aim of this study is to evaluate the utility of visualizing atherosclerotic plaques with radiolabeled duramycin and Annexin V. PROCEDURES: ApoE-/- mice were fed with a high-fat diet to develop atherosclerosis, C57 mice as a control. Using a routine conjugation protocol, highly pure [99mTc]duramycin and [99mTc]Annexin V were obtained, which were applied for in vitro cell assays of apoptosis and in vivo imaging of atherosclerotic plaques in the animal model. Oil Red O staining, TUNEL, hematoxylin-eosin (HE), and CD68 immunostaining were used to evaluate the deposition of lipids and presence of apoptotic macrophages in the lesions where focal intensity positively correlated with the uptake of both tracers. RESULTS: [99mTc]duramycin and [99mTc]Annexin V with a high radiochemical purity (97.13 ± 1.52 and 94.94 ± 0.65 %, respectively) and a well stability at room temperature were used. Apoptotic cells binding activity to [99mTc]duramycin (Kd, 6.92 nM and Bmax, 56.04 mol/1019 cells) was significantly greater than [99mTc]Annexin V (Kd, 12.63 nM and Bmax, 31.55 mol/1019 cells). Compared with [99mTc]Annexin V, [99mTc]duramycin bound avidly to atherosclerotic lesions with a higher plaque-to-background ratio (P/B was 8.23 ± 0.91 and 5.45 ± 0.48 at 20 weeks, 15.02 ± 0.23 and 12.14 ± 0.22 at 30 weeks). No plaques were found in C57 control mice. Furthermore, Oil Red O staining showed lipid deposition areas were significantly increased in ApoE-/- mice at 20 and 30 weeks, and TUNEL and CD68 staining confirmed that the focal uptake of both tracers contained abundant apoptotic macrophages. CONCLUSIONS: This stable, fast clearing, and highly specific [99mTc]duramycin, therefore, can be useful for the quantification of vulnerable atherosclerotic plaques.
PURPOSE: Apoptosis is a key factor in unstable plaques. The aim of this study is to evaluate the utility of visualizing atherosclerotic plaques with radiolabeled duramycin and Annexin V. PROCEDURES: ApoE-/- mice were fed with a high-fat diet to develop atherosclerosis, C57 mice as a control. Using a routine conjugation protocol, highly pure [99mTc]duramycin and [99mTc]Annexin V were obtained, which were applied for in vitro cell assays of apoptosis and in vivo imaging of atherosclerotic plaques in the animal model. Oil Red O staining, TUNEL, hematoxylin-eosin (HE), and CD68 immunostaining were used to evaluate the deposition of lipids and presence of apoptotic macrophages in the lesions where focal intensity positively correlated with the uptake of both tracers. RESULTS: [99mTc]duramycin and [99mTc]Annexin V with a high radiochemical purity (97.13 ± 1.52 and 94.94 ± 0.65 %, respectively) and a well stability at room temperature were used. Apoptotic cells binding activity to [99mTc]duramycin (Kd, 6.92 nM and Bmax, 56.04 mol/1019 cells) was significantly greater than [99mTc]Annexin V (Kd, 12.63 nM and Bmax, 31.55 mol/1019 cells). Compared with [99mTc]Annexin V, [99mTc]duramycin bound avidly to atherosclerotic lesions with a higher plaque-to-background ratio (P/B was 8.23 ± 0.91 and 5.45 ± 0.48 at 20 weeks, 15.02 ± 0.23 and 12.14 ± 0.22 at 30 weeks). No plaques were found in C57 control mice. Furthermore, Oil Red O staining showed lipid deposition areas were significantly increased in ApoE-/- mice at 20 and 30 weeks, and TUNEL and CD68 staining confirmed that the focal uptake of both tracers contained abundant apoptotic macrophages. CONCLUSIONS: This stable, fast clearing, and highly specific [99mTc]duramycin, therefore, can be useful for the quantification of vulnerable atherosclerotic plaques.
Authors: Murugesan Subbarayan; Urs O Häfeli; Denise K Feyes; Jaya Unnithan; Steven N Emancipator; Hasan Mukhtar Journal: J Nucl Med Date: 2003-04 Impact factor: 10.057
Authors: Lei Wang; Feng Wang; Wei Fang; Steven E Johnson; Said Audi; Michael Zimmer; Thomas A Holly; Daniel C Lee; Bao Zhu; Haibo Zhu; Ming Zhao Journal: Nucl Med Biol Date: 2014-09-23 Impact factor: 2.408
Authors: Mathias Burgmaier; Kristof Schutters; Brecht Willems; Emiel P C van der Vorst; Dennis Kusters; Martijn Chatrou; Lucy Norling; Erik A L Biessen; Jack Cleutjens; Mauro Perretti; Leon J Schurgers; Chris P M Reutelingsperger Journal: J Cell Mol Med Date: 2014-09-12 Impact factor: 5.310
Authors: Farhan Chaudhry; Hideki Kawai; Kipp W Johnson; Navneet Narula; Aditya Shekhar; Fayzan Chaudhry; Takehiro Nakahara; Takashi Tanimoto; Dongbin Kim; Matthew K M Y Adapoe; Francis G Blankenberg; Jeffrey A Mattis; Koon Y Pak; Phillip D Levy; Yukio Ozaki; Eloisa Arbustini; H William Strauss; Artiom Petrov; Valentin Fuster; Jagat Narula Journal: J Am Coll Cardiol Date: 2020-10-20 Impact factor: 24.094